Diagnosis and Treatment of Hypercortisolism (Cushing's Syndrome)
The diagnosis of hypercortisolism requires a stepwise approach starting with screening tests followed by confirmatory testing, while treatment must be directed at the underlying cause, with surgical resection of the responsible tumor being the first-line therapy for most forms of Cushing's syndrome. 1
Clinical Manifestations
Key Clinical Features
- Weight gain with central obesity
- Facial plethora (moon facies)
- Supraclavicular and dorsocervical fat pads ("buffalo hump")
- Purple striae (>1 cm wide)
- Proximal muscle weakness
- Easy bruising
- Hirsutism and menstrual irregularities in women
- Decreased libido and erectile dysfunction in men
- Psychiatric disturbances (depression, anxiety, cognitive impairment)
High-Specificity Features
- Growth deceleration with weight gain in children - this combination has high sensitivity and specificity for Cushing's syndrome in pediatric patients 1
- Wide (>1 cm) purple striae
- Proximal myopathy
- Facial plethora
- Spontaneous ecchymoses
Comorbidities
- Hypertension
- Glucose intolerance/diabetes mellitus
- Osteoporosis/pathologic fractures
- Thromboembolic events
- Recurrent infections
- Cardiovascular disease
Diagnostic Approach
Step 1: Rule Out Exogenous Causes
- Confirm patient is not taking exogenous glucocorticoids (oral, injections, topical, inhaled)
Step 2: Initial Screening Tests (perform at least two)
- Late-night salivary cortisol (LNSC) - collect at 22:00-23:00 hours (≥2 samples on separate days)
- 24-hour urinary free cortisol (UFC) - collect 2-3 samples
- 1mg overnight dexamethasone suppression test (DST) - failure to suppress morning cortisol to <50 nmol/L (<1.8 μg/dL)
Step 3: Determine ACTH Dependency
- Measure plasma ACTH level
- Low/suppressed ACTH (<5-10 pg/mL): ACTH-independent (adrenal cause)
- Normal/elevated ACTH: ACTH-dependent (pituitary or ectopic source)
Step 4: Localization Studies
- For ACTH-independent causes: Adrenal CT or MRI
- For ACTH-dependent causes: Pituitary MRI
- If pituitary MRI negative or equivocal: Inferior petrosal sinus sampling (IPSS)
- If IPSS negative for central source: CT chest/abdomen/pelvis to locate ectopic source
Treatment Algorithm
1. Cushing's Disease (Pituitary ACTH-Secreting Adenoma)
- First-line: Transsphenoidal surgery (TSS)
- Success rates: 65-90% for microadenomas, lower for macroadenomas
- For persistent/recurrent disease:
- Second TSS
- Radiation therapy (conventional or stereotactic radiosurgery)
- Medical therapy
- Bilateral adrenalectomy
2. Adrenal Causes (Adenoma, Carcinoma, Bilateral Hyperplasia)
- First-line: Surgical resection
- Unilateral adrenalectomy for adenoma/carcinoma
- Bilateral adrenalectomy for bilateral disease
3. Ectopic ACTH Syndrome
- First-line: Surgical resection of the ACTH-producing tumor
- If tumor unidentified or unresectable: Medical therapy
4. Medical Therapy Options
Adrenal enzyme inhibitors:
- Ketoconazole: 400-1200 mg/day (divided doses)
- Monitor liver function tests regularly
- Avoid in patients on PPIs (requires gastric acid for absorption)
- Metyrapone: 500-6000 mg/day (divided doses)
- Monitor for hirsutism and hypertension
- Osilodrostat: 2-7 mg twice daily (FDA-approved for Cushing's disease)
- Monitor for hirsutism, hypertension, hypokalemia
- Ketoconazole: 400-1200 mg/day (divided doses)
Pituitary-directed:
- Pasireotide: 0.6-0.9 mg twice daily subcutaneously
- Monitor for hyperglycemia
- Pasireotide: 0.6-0.9 mg twice daily subcutaneously
Special Considerations
Diagnostic Pitfalls
- Pseudo-Cushing's states can cause mild hypercortisolism:
- Severe obesity
- Depression
- Alcoholism
- Poorly controlled diabetes
- Polycystic ovary syndrome
- Consider monitoring for 3-6 months if mild hypercortisolism present
Pediatric Considerations
- Different clinical presentation with growth failure and weight gain being key features 1
- Male predominance in prepubertal children (unlike adult female predominance)
- Microadenomas account for 98% of pediatric Cushing's disease cases
- Thromboprophylaxis should not be routinely used in pediatric patients undergoing surgery
Post-treatment Monitoring
- All patients require lifelong monitoring for:
- Recurrence of hypercortisolism
- Adrenal insufficiency (after successful treatment)
- Persistent comorbidities (hypertension, diabetes, osteoporosis)
Treatment Outcomes
- Mortality is significantly reduced with successful treatment
- Some comorbidities may persist despite biochemical cure
- Quality of life improves but may not normalize completely
- Early diagnosis and treatment leads to better outcomes
Remember that early diagnosis and expert management are critical given the potential for long-term adverse health outcomes from prolonged hypercortisolism 1. Patients should be referred to centers with expertise in managing pituitary and adrenal disorders.